Skip to content

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again

      Home/Our innovation /Focus areas/Neuroscience/Partner with us

      Partner with us

      Share Article
      Share to
      We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.”

      Our global presence and cross-business portfolio provide us with the flexibility to build strong relationships and become the partner of choice for many collaborative opportunities in both established and emerging markets. In emerging markets, our vision is to enable the delivery of quality medicines, harness growth and expand businesses. We welcome opportunities to develop partnerships with companies in emerging markets that want to leverage their innovative products and technologies.

      Our approaches to partnering

      We have successfully established many partnerships and innovative deal structures, and we are continuously seeking new ways to collaborate in our core areas of interest, including:

      • Licensing and acquisition opportunities for therapeutics against novel targets
      • Academic partnerships where novel discoveries have revealed high potential targets for therapeutic or diagnostic development
      • Public-private partnerships and collaborations to advance therapeutics, clinical trials and biomarker programs
      • Opportunities to license out and reposition selected compounds in our neuroscience pipeline
      • Other innovative business structures such as venture investments, option deals and risk-sharing relationships

      Our specialties

      • Alzheimer’s Disease
      • Parkinson’s Disease
      • Depression
      • Bipolar Disorder
      • Schizophrenia

      If you have a licensing candidate or program idea in this area, please contact us with your idea.